Research Overview: Stanozol-50 Laboratory Compound
Stanozolol is a synthetic anabolic-androgenic steroid derivative originally developed for veterinary research applications. Stanozol-50 by Lyka Labs represents a standardised research formulation containing 50mg of stanozolol per tablet, manufactured under controlled laboratory conditions. This compound belongs to the dihydrotestosterone derivative family and exhibits unique structural modifications that distinguish it from testosterone-based compounds. Research scientists investigating anabolic pathways often examine stanozolol for its distinctive molecular characteristics and receptor binding profiles. The compound’s chemical structure includes a pyrazole ring attachment that significantly alters its pharmacological properties compared to other synthetic steroids. Stroid UK Shop frequently utilise standardised stanozolol preparations for comparative studies examining cellular protein synthesis mechanisms.
Laboratory Research Applications
Contemporary research investigations examine stanozolol’s interactions with androgen receptors and its influence on cellular signalling pathways. Scientists analyse how this compound affects nitrogen retention mechanisms within muscle tissue samples during in-vitro studies. Molecular biology research focuses on stanozolol’s impact on gene expression patterns, particularly those governing protein synthesis and cellular growth factors. Comparative studies evaluate the compound’s binding affinity to sex hormone-binding globulin and its subsequent effects on cellular metabolism. Researchers investigating anabolic processes utilise stanozolol to study the relationship between steroid receptor activation and downstream cellular responses. Stanozolol research compounds serve as valuable tools for examining hepatic enzyme interactions and metabolic pathway modifications. Scientists also investigate the compound’s effects on collagen synthesis and bone matrix formation in laboratory tissue cultures. Advanced research protocols examine stanozolol’s influence on various growth factors and cytokine production in controlled experimental conditions.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Stanozolol |
| Concentration | 50mg per tablet |
| Pack Quantity | 100 tablets |
| Manufacturer | Lyka Labs |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage | Room temperature, dry conditions |
Research institutions comparing stanozolol with selective androgen receptor modulators frequently examine receptor selectivity differences and tissue-specific responses. Parallel investigations often include peptide research compounds to evaluate combined effects on cellular signalling cascades.
Research Use Compliance
Stanozol-50 is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any form of personal application. This product is designed for qualified research institutions and licensed laboratories conducting legitimate scientific investigations.
